Home » UPC decisions » Regional Division » Nordic-Baltic Regional Division » RD Nordic-Baltic, September 18, 2024, Procedural Order on a request for access to the written pleadings and evidence, UPC_CFI_8/2023

RD Nordic-Baltic, September 18, 2024, Procedural Order on a request for access to the written pleadings and evidence, UPC_CFI_8/2023

2 min Reading time

Key takeaways

The UPC clarified that a “reasoned request” under Rule 262.1(b) RoP requires more than a general interest. The applicant must provide a specific and credible explanation for needing access to court documents, demonstrating a genuine need beyond publicly available information

In this case, the applicant’s status as a competitor and their interest in the patent’s validity were insufficient to grant access, as the relevant information was already publicly available.

The decision underscores the UPC’s commitment to balancing the principle of open justice (Article 45 UPCA) with the right to a fair trial. The court emphasized that transparency should not compromise the parties’ ability to present their cases freely and fairly.

Division

Nordic-Baltic Regional Division

UPC number

UPC_CFI_8/2023

ACT_459769/2023, ORD_36465/2024

App_33487/2024, App_33489/2024, App_33485/2024, App_33473/2024, App_33475/2024, App_33476/2024, App_33478/2024, App_33480/2024, App_33481/2024

Type of proceedings

Request for access to written pleadings and evidence (Rule 262.1(b) RoP) within a patent infringement action.

Parties

Applicant: Erik Krahbichler

Claimant: Edwards Lifesciences Corporation

Defendants: Meril Lifesciences PVT Limited, Meril GmbH, Smis International OÜ, Sormedica UAB

Patent(s)

EP 2 628 464

EP 3 646 825

EP 3 669 828

EP 3 769 722

Body of legislation / Rules

Rule 262.1(b) RoP

Article 45 UPCA


Was the article helpful?


Categories


Tags

Stay in the loop

Never miss a beat by subscribing to the email newsletter. Please see our Privacy Policy.

* = Required field